Mark Borodkin
No más puestos en curso
Fortuna: 241 242 $ al 30/04/2024
Perfil
Mark Borodkin worked as a Chief Product Officer & Engineering Director at Azenta, Inc. He was an Engineering Director at Affymetrix, Inc. from 2009 to 2011.
He worked as a Senior Manager at Siemens Healthcare Diagnostics, Inc. from 2007 to 2009.
He was a Senior Manager-Engineering at Applied Biosystems, Inc. He also worked as a Vice President-Systems Development at Bionano Genomics, Inc. from 2014 to 2017.
Mr. Borodkin received his undergraduate degree in 1995 and his graduate degree in 2004 from Rensselaer Polytechnic Institute.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
BIONANO GENOMICS, INC.
0.52% | 18/09/2023 | 317 842 ( 0.52% ) | 241 242 $ | 30/04/2024 |
Antiguos cargos conocidos de Mark Borodkin.
| Empresas | Cargo | Fin |
|---|---|---|
| AFFYMETRIX, INC. | Director Técnico/Científico/I+D | 01/10/2011 |
Siemens Healthcare Diagnostics, Inc.
 Siemens Healthcare Diagnostics, Inc. Medical/Nursing ServicesHealth Services Siemens Healthcare Diagnostics, Inc. engages in the vitro diagnostics. It provides healthcare professionals in hospital, reference, and physician office laboratories and point-of-care settings with the vital information required to accurately diagnose, treat, and monitor patients. The company is headquartered in Tarrytown, NY. | Corporate Officer/Principal | 01/04/2009 |
Applied Biosystems, Inc.
 Applied Biosystems, Inc. Medical SpecialtiesHealth Technology Applied Biosystems, Inc. is a company that provides integrated systems for sequencing, flow cytometry, and various types of PCR. The company is based in Foster City, CA. The company's products cover the entire process from sample preparation to data analysis. The company was founded by Chris Yoo, Marvin H. Caruthers, Michael W. Hunkapiller, and Leroy E. Hood. Applied Biosystems was acquired by Invitrogen Corp. from Applera Corp. on November 21, 2008 for $6,417.85 million. | Director Técnico/Científico/I+D | - |
| AZENTA, INC. | Corporate Officer/Principal | - |
| BIONANO GENOMICS, INC. | Director de Operaciones | - |
Formación de Mark Borodkin.
| Rensselaer Polytechnic Institute | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| BIONANO GENOMICS, INC. | Health Technology |
| AZENTA, INC. | Health Services |
| Empresas privadas | 3 |
|---|---|
Affymetrix, Inc.
 Affymetrix, Inc. Medical SpecialtiesHealth Technology Affymetrix, Inc. develops, manufactures and sells products and services for genetic analysis. The company was founded by Stephen P. A. Fodor in 1992 and is headquartered in Santa Clara, CA. | Health Technology |
Siemens Healthcare Diagnostics, Inc.
Siemens Healthcare Diagnostics, Inc. Medical/Nursing ServicesHealth Services Siemens Healthcare Diagnostics, Inc. engages in the vitro diagnostics. It provides healthcare professionals in hospital, reference, and physician office laboratories and point-of-care settings with the vital information required to accurately diagnose, treat, and monitor patients. The company is headquartered in Tarrytown, NY. | Health Services |
Applied Biosystems, Inc.
Applied Biosystems, Inc. Medical SpecialtiesHealth Technology Applied Biosystems, Inc. is a company that provides integrated systems for sequencing, flow cytometry, and various types of PCR. The company is based in Foster City, CA. The company's products cover the entire process from sample preparation to data analysis. The company was founded by Chris Yoo, Marvin H. Caruthers, Michael W. Hunkapiller, and Leroy E. Hood. Applied Biosystems was acquired by Invitrogen Corp. from Applera Corp. on November 21, 2008 for $6,417.85 million. | Health Technology |
- Bolsa de valores
- Insiders
- Mark Borodkin
